The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden administration’s key achievement.

The high court’s most unusual case of the current term will determine if our trademark laws are all bark and no bite.

Devotees of the legendary role-playing game could end up on the losing side of the next big intellectual property war.

In a potentially significant case about parody and intellectual property, the high court may get the last laugh.

Big Pharma and cowardly leaders in the Global North have left poor countries vulnerable to the most contagious Covid variant yet.

Gates was a lovable nerd who was out to save the world. Now, he’s a tech supervillain who wants to protect profits over public health.

Not long ago, life-saving medical know-how was viewed as belonging to everyone. What happened?

The e-commerce giant covets the Hollywood studio’s sweet, sweet cache of intellectual property.

Corporate America might protest, but the potential of a patent waiver on Covid-19 vaccines is worth celebrating—and fighting for.

Nations across the world are demanding the right to manufacture their own Covid-19 vaccines. Why is the U.S. saying no?

The race for a cure has put a spotlight on corporate control over medical research. Under a Democratic administration, it doesn’t have to be that way.

Why we can't leave pandemic prevention to Big Pharma

Privatizing lifesaving technology like vaccines and clean energy is bad for both the coronavirus and the climate crisis.

A practical blueprint for reform in the wake of the coronavirus shutdown

Competition among private medical interests is impeding the race for the cure.

That's one consultant's advice, anyway, for paranoid companies